• 1
    Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. Human kallikrein 2 (hK2) and prostate specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 1998;35: 275368.
  • 2
    Brown LG, Wegner SK, Wang H, et al. A novel monoclonal antibody (107-1A4) with high prostate specificity: generation, characterization of antigen expression, and targeting of human prostate cancer xenografts. Prostate Cancer Prostatic Dis 1998;1: 20815.
  • 3
    Hutchens TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993;7: 57680.
  • 4
    Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000;21: 116477.
  • 5
    Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987;7: 92736.
  • 6
    Grauer LS, Lawler KD, Marignac JL, Kumar A, Goel AS, Wolfert RL. Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM′ protein in the LNCaP prostatic carcinoma cell line. Cancer Res 1998;58: 47879.
  • 7
    Smith-Jones P, Vallabahajosula S, Goldsmith SJ, et al. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Cancer Res 2000;60: 523743.
  • 8
    Gregorakis AK, Holmes EH, Murphy GP. Prostate-specific membrane antigen: current and future utility. Semin Urol Oncol 1998;16: 2–-12.
  • 9
    Wright GL Jr, Cazares LH, Leung S-M, et al. ProteinChip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostate Dis 1999;2: 26476.
  • 10
    Xiao Z, Jiang X, Beckett ML, Wright GL Jr. A recombinant prostate specific membrane antigen for development of a novel biochip immunoassay. Protein Express Purification 2000;19: 1221.
  • 11
    Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76: 435054.
  • 12
    Jensen ON, Podtelejnikov AV, Mann M. Identification of the components of simple protein mixtures by high-accuracy peptide mass mapping and database searching. Anal Chem 1997;69: 474150.
  • 13
    Holmes EH, Greene TG, Tino WT, et al. Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients. Prostate Suppl 1996;7: 259.
  • 14
    Scheler C, Lamer S, Pan Z, Li XP, Salnikow J, Jungblut P. Peptide mass fingerprint sequence coverage from differently stained proteins on two-dimensional electrophoresis patterns by matrix assisted laser desorption/ionization-mass spectrometry (MALDI-MS). Electrophoresis 1998;19: 91827.
  • 15
    Cohen SL, Chait BT. Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins. Anal Chem 1996;68: 317.
  • 16
    Krause E, Wenschuh H, Jungblut PR. The dominance of arginine-containing peptides in MALDI-derived tryptic mass fingerprints of proteins. Anal.Chem 1999; 71: 41605.
  • 17
    Kussmann M, Lassing U, Sturmer CA, Przybylski M, Roepstorff P. Matrix-assisted laser desorption/ionization mass spectrometric peptide mapping of the neural cell adhesion protein neurolin purified by sodium dodecyl sulfate polyacrylamide gel electrophoresis or acidic precipitation. J Mass Spectrom 1997;32: 48393.
  • 18
    Olumee Z, Sadeghi M, Tang X, Vertes A. Amino acid composition and wavelength effects in matrix-assisted laser desorption/ionization. Rapid Commun Mass Spectrom 1995;9: 74452.
  • 19
    Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282: 131821.
  • 20
    Hinshelwood J, Spencer DI, Edwards YJ, Perkins SJ. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B. J Mol Biol 1999; 294: 58799.
  • 21
    Davies H, Lomas L, Austen B. Profiling of amyloid beta peptide variants using SELDI Protein Chip arrays. Biotechniques 1999;27: 125861.
  • 22
    Beher D, Lewis HD, Clarke E, et al. Poster- 240.13: amyloid-B peptide profiles in human Alzheimer's brain and conditioned media of transfected cell lines determined by SELDI-TOF mass spectrometry. Society for Neuroscience Meeting, October 23–28, 1999, Miami Beach, FL. Poster Session: Degenerative disease: Alzheimer's beta amyloid: APP processing II.
  • 23
    Frears ER, Stephens DJ, Walters CE, Davies H, Austen BM. The role of cholesterol in the biosynthesis of beta-amyloid. Neuroreport 1999;10: 1699705.
  • 24
    Li YM, Lai MT, Xu M, et al. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA 2000;97: 613843.